NEUMORA THERAPEUTICS, INC. Preferred Shares: Authorized and Outstanding
The company's filed XBRL preferred stock facts (us-gaap Preferred*), one row per period end, newest first. Values are as filed.
- 2026-06-30: Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2026-03-31: Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-12-31: Preferred Stock, Par or Stated Value Per Share $0.00; Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
- 2025-09-30: Preferred Stock, Shares Authorized 50.00M shares; Preferred Stock, Shares Issued 0.00 shares; Preferred Stock, Shares Outstanding 0.00 shares.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Shares Authorized | Preferred Stock, Shares Issued | Preferred Stock, Shares Outstanding | Preferred Stock, Value, Issued | Preferred Stock, Value, Outstanding |
|---|---|---|---|---|---|---|
| 2026-06-30 | 50.00M shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | 0.00 shares 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | 50.00M shares 10-Q · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | 0.00 shares 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | $0.00 10-K · filed 2026-03-30 | 50.00M shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | ||
| 2025-09-30 | 50.00M shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | 0.00 shares 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | 50.00M shares 10-Q · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | 0.00 shares 10-Q · filed 2025-08-06 | |||
| 2025-03-31 | 50.00M shares 10-Q · filed 2025-05-12 | 0.00 shares 10-Q · filed 2025-05-12 | 0.00 shares 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | $0.00 10-K · filed 2026-03-30 | 50.00M shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | 0.00 shares 10-K · filed 2026-03-30 | ||
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-12 | 0.00 shares 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 0.00 shares 10-Q · filed 2024-08-06 | 0.00 shares 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | 0.00 shares 10-Q · filed 2024-05-07 | 0.00 shares 10-Q · filed 2024-05-07 | ||||
| 2023-12-31 | $0.00 10-K · filed 2025-03-03 | 50.00M shares 10-K · filed 2025-03-03 | 0.00 shares 10-K · filed 2025-03-03 | 0.00 shares 10-K · filed 2025-03-03 | $0.00 10-K · filed 2024-03-07 | $0.00 10-K · filed 2024-03-07 |
| 2023-09-20 | 50.00M shares 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |